ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 47 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $33,000 | +3200.0% | 174,988 | +6630.3% | 0.00% | – |
Q1 2022 | $1,000 | -80.0% | 2,600 | +98.9% | 0.00% | – |
Q3 2019 | $5,000 | -61.5% | 1,307 | -58.2% | 0.00% | – |
Q2 2019 | $13,000 | -40.9% | 3,128 | -0.4% | 0.00% | – |
Q1 2019 | $22,000 | +37.5% | 3,142 | +3.2% | 0.00% | – |
Q4 2018 | $16,000 | -52.9% | 3,044 | -4.3% | 0.00% | – |
Q3 2018 | $34,000 | +54.5% | 3,182 | +91.0% | 0.00% | – |
Q2 2018 | $22,000 | +175.0% | 1,666 | +133.7% | 0.00% | – |
Q1 2018 | $8,000 | +33.3% | 713 | +17.3% | 0.00% | – |
Q4 2017 | $6,000 | – | 608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |